Trademark Trial and Appeal Board Electronic Filing System. http://estta.uspto.gov
`
`ESTTA Tracking number:
`
`ESTTA1119891
`
`Filing date:
`
`03/11/2021
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`Proceeding
`
`Applicant
`
`88877980
`
`Live Good Inc
`
`Applied for Mark
`
`GENRESTORE
`
`Correspondence
`Address
`
`REINE ROONEY
`REINE ROONEY LLC
`9565 MUNSON HILL ROAD
`BRADFORD, NY 14815
`UNITED STATES
`Primary Email: reine.glanz@gmail.com
`Secondary Email(s): reine.glanz@gmail.com
`9173347043
`
`Submission
`
`Attachments
`
`Appeal Brief
`
`GENRESTORE_Appeal Brief.pdf(125489 bytes )
`Exhibit A.pdf(1461548 bytes )
`Exhibit B_Redacted.pdf(2744311 bytes )
`
`Appealed class
`
`Class 005. First Use: 2018/10/22 First Use In Commerce: 2018/10/22
`All goods and services in the class are appealed, namely: Dietary supplements
`
`Filer's Name
`
`Filer's email
`
`Signature
`
`Date
`
`Reine Rooney
`
`reine.glanz@gmail.com
`
`/Reine Rooney/
`
`03/11/2021
`
`

`

`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`TRADEMARK TRIAL AND APPEAL BOARD (TTAB)
`
`
`
`Applicant
`
`Serial No.
`
`Filed
`
`Mark
`
`
`
`
`
`:
`
`:
`
`:
`
`:
`
`Live Good Inc
`
`88877980
`
`
`
`Examiner: MAHMOUDI, MARIAM AZIZ
`
`April 19, 2020
`
`Law Office: 115
`
`GENRESTORE
`
`
`
`Trademark Trial and Appeal Board
`Commissioner for Trademarks
`P.O. Box 1451
`Alexandria, VA 22313-1451
`
`
`
`APPLICANT'S APPEAL BRIEF
`
`In response to the Final Office Action dated February 13, 2021, and further in view of the
`
`Notice of Appeal filed March 11, 2021. Applicant respectfully submits the following remarks.
`
`I.
`
`Summary of the Rejections
`
`In the Final Office Action, the Applicant’s application is rejected under Trademark Act
`
`Section 2(d), 15 U.S.C. §1052(d) for being confusingly similar to U.S. Trademark Registration
`
`No. 5565178 for RESTOREGEN (hereinafter the “Registered Mark”).
`
`Applicant respectfully disagrees with the Examiner’s rejection based on a likelihood of
`
`confusion based on the prior registered mark.
`
`II.
`
`The Marks At Issue
`
`The Applied for Mark, GENRESTORE, designates dietary supplements.
`
`The Registered Mark, RESTOREGEN, designates dietary supplements; natural dietary
`
`supplements for the treatment of substance and non-substance behavior cravings; natural dietary
`
`supplements for the treatment of pro-dopamine regulator.
`
`
`
`1
`
`

`

`III. There is No Likelihood of Confusion Between the Marks
`
`Applicant respectfully contends that the Applied for Mark does not have any resemblance
`
`in sound, appearance, meaning, or commercial impression to the Registered Mark.
`
`Nor is registration of Applicant's mark likely to cause confusion, or to cause mistake, or to
`
`deceive. An examination of the relevant factors under TMEP §1207 and In re E.I. du Pont de
`
`Nemours & Co., 177 USPQ 563, 567 (C.C.P.A. 1973), warrants the conclusion that Applicant's
`
`Mark cannot be said to so resemble the Cited Mark that it is likely to cause confusion, or to cause
`
`mistake,
`
`A. The Marks have Different Meanings and Commercial Impressions
`
`The Examiner argues that the marks are similar in appearance, sound, connotation, and
`
`commercial impression. The undersigned respectfully disagrees. While both marks contain the
`
`elements “GEN” and “RESTORE,” the elements appear in a separate order. That is,
`
`GENRESTORE contains the “GEN” element first, with the “RESTORE” element second; while
`
`RESTOREGEN contains the “RESTORE” element first with the “GEN” element second. For this
`
`reason, the undersigned submits that the marks have a distinct appearance, sound, connotation, and
`
`commercial impression.
`
`The Cited Mark refers to restoring (restore) a genetic (gen) response to prevent addictive
`
`behavior by treating pro-dopamine regulators.
`
`The Applicant’s mark refers to generation (gen) and restore.
`
`Applicant submits that the Registered Mark “creates a vastly different commercial
`
`impression than that of Applicant’s mark.” “[T]he reversal in one mark of the essential elements
`
`of another mark may serve as a basis for a finding of no likelihood of confusion only if the
`
`transposed marks create distinctly different commercial impressions.” In re Nationwide Indus.
`
`
`
`2
`
`

`

`Inc., 6 USPQ2d 1882, 1884 (TTAB 1988), (emphasis added). See also Bank of Am. Nat’l Trust
`
`and Sav. Assn. v. Am. Nat’l Bank of St. Joseph, 201 USPQ 842, 845 (TTAB 1978), and cases
`
`cited therein. Cases on point include In re Mavest, Inc., 130 USPQ 40 (TTAB 1961) (finding no
`
`likelihood of confusion between the marks TOWN SQUIRES and SQUIRETOWN because
`
`transposition of words creates distinctly different commercial impressions); and In re Akzona Inc.,
`
`219 USPQ 94 (TTAB 1983) (finding no likelihood of confusion between SILKY TOUCH for
`
`synthetic yarns and TOUCH O’ SILK for men’s dress shirts, sport shirts, and pajamas because of
`
`different commercial impressions).
`
`As such since the commercial impressions of Applicant’s mark and the Registered Mark
`
`are different, the marks are not similar when compared in their entireties.
`
`B. The Registered Mark is Weak
`
` “In determining the strength of a mark, we consider both its inherent strength based on the
`
`nature of the mark itself and its commercial strength, based on the marketplace recognition value
`
`of the mark.” American Lebanese Syrian Associated Charities Inc. v. Child Health Research Inst.,
`
`101 USPQ2d 1022, 1028 (TTAB 2011 (citing Tea Board of India v. Republic of Tea Inc., 80
`
`USPQ2d 1881, 1899 (TTAB 2006) and McCarthy on Trademarks and Unfair Competition § 11:83
`
`(4th ed. 2011) (“The first enquiry focuses on the inherent potential of the term at the time of its
`
`first use. The second evaluates the actual customer recognition value of the mark at the time
`
`registration is sought or at the time the mark is asserted in litigation to prevent another's use.”)).
`
`“[T]he strength of a mark is not a binary factor” and “varies along a spectrum from very strong to
`
`very 3 See January 8, 2016 Office Action pp. 5-13. Serial Nos. 86759729 - 7 - weak.” Juice
`
`Generation, Inc. v. GS Enters. LLC, 794 F.3d 1334, 115 USPQ2d 1671, 1675-76 (Fed. Cir. 2015)
`
`(internal citations omitted). “The weaker [the Registrant’s] mark, the closer an applicant’s mark
`
`
`
`3
`
`

`

`can come without causing a likelihood of confusion and thereby invading what amounts to its
`
`comparatively narrower range of protection.” Id. at 1676 (internal citations omitted). See also Palm
`
`Bay, 73 USPQ2d at 1693 (“Evidence of third-party use of similar marks on similar goods is
`
`relevant to show that a mark is relatively weak and entitled to only a narrow scope of protection.”).
`
`Applicant submits that “the Register abounds with marks beginning with the word
`
`RESTORE (221) for Class 005 goods. As such, the Registered Mark RESTOREGEN is weak for
`
`Registrant’s identified goods. A search of the Trademark Office database shows 98 marks
`
`commencing with the word “RESTORE” in International Class 003 and 95 third-party marks
`
`containing the word “GEN” in International Class 003. Evidence of extensive registration and use
`
`by others of a term on the same or very similar services can be “powerful” evidence of weakness.
`
`See Jack Wolfskin Ausrustung Fur Draussen GmbH & Co. KGAA v. New Millennium Sports,
`
`S.L.U., 797 F.3d 1363, 116 USPQ2d 1129, 1136 (Fed. Cir. 2015); Juice Generation, 115 USPQ2d
`
`at 1674. Active third-party registrations may also be relevant to show that a mark or 4 See April
`
`2, 2016 Office Action Response pp. 14-19. 5 See June 8, 2016 Request for Reconsideration pp. 2-
`
`16. Serial Nos. 86759729 - 8 - a portion of a mark is descriptive, suggestive, or so commonly used
`
`in a particular industry that the public will look to other elements to distinguish the source of the
`
`services. See Juice Generation, 115 USPQ2d at 1674-75. See also Tektronix, Inc. v. Daktronics,
`
`Inc., 534 F.2d 915, 189 USPQ 693, 694-95 (CCPA 1976); In re J.M. Originals Inc., 6 USPQ2d
`
`1393, 1394 (TTAB 1987); United Foods Inc. v. J.R. Simplot Co., 4 USPQ2d 1172, 1174 (TTAB
`
`1987).
`
`Furthermore, based on the dictionary definition of “restore” (to bring back into existence,
`
`use, or the like; reestablish: to restore order: to bring back to a former, original, or normal
`
`condition, as a building, statue, or painting See https://www.dictionary.com/browse/restore)
`
`
`
`4
`
`

`

`“Restore” is highly descriptive of the goods. When coupled with the adjective “gen”, the
`
`result is a compound word mark that is highly suggestive. See, e.g., Drackett Co. v. H. Kohnstamm
`
`& Co., 404 F.2d 1399, 160 USPQ 407, 408 (CCPA 1969) (“Although ENDUST may not be
`
`descriptive in the sense that the product actually ends dust or dusting, the mark is suggestive.”).
`
`“Marks that are descriptive or highly suggestive are entitled to a narrower scope of protection, i.e.,
`
`are less likely to generate confusion over source identification, than their more fanciful
`
`counterparts.” Juice Generation, 115 USPQ2d at 1675. See also Drackett Co. v. H. Kohnstamm &
`
`Co., 160 USPQ at 408 (“The scope of protection afforded such highly suggestive marks is
`
`necessarily narrow and confusion is not likely to result from the use of two marks carrying the
`
`same suggestion as to the use of closely similar goods.”). Because the Registered Mark is highly
`
`suggestive and therefore conceptually weak, this du Pont factor weighs against finding a likelihood
`
`of confusion.
`
`C. The Goods are Unrelated and the Degree of Care Exercised by Consumers of The
`
`Applicant’s Goods and the Goods Offered by Registrant is Heightened
`
`Given the commercial reality of the goods at issue, it is not just unlikely, but almost
`
`inconceivable that the respective relevant consumers would mistakenly believe that the parties'
`
`goods originate from the same source or that a connection or sponsorship exists when faced with
`
`the Registered Mark versus Applicant's Mark.
`
`The Registered Mark designates the following goods: “Dietary supplements; natural dietary
`
`supplements for the treatment of substance and non-substance behavior cravings; natural dietary
`
`supplements for the treatment of pro-dopamine regulator.” The Registered Mark’s goods are
`
`marketed as a “patented neuro-nutrient formulation,” “innovative approach to precision addiction
`
`management,” “specific formulation matched to individual genetics,” and “pro-dopamine
`
`
`
`5
`
`

`

`regulator decreases addictive behavior cravings.” See Exhibit A. This product works as a pro-
`
`dopamine regulator that decreases substance and non-substance craving behaviors. The
`
`formulation includes neuro-nutrient technology in re-balancing brain chemistry and optimizing
`
`dopamine sensitivity and function. To obtain this medicine, a consumer needs to go through an
`
`authorized provider and needs to have their cheek swabbed to determine the correct formulation,
`
`where a specific formulation is matched to individual genetics. This means that a consumer cannot
`
`merely purchase the supplement “off the shelf.” Because of the level of involvement the consumer
`
`must partake, they would be very discerning and aware of the product they are purchasing.
`
`The Applied for Mark designates “Dietary supplements.” Attached as Exhibit B are
`
`examples of the types of supplements the Applicant sells under the GENRESTORE mark. Rather
`
`than being a specific formula that rebalances brain chemistry and optimizes dopamine sensitivity
`
`and function that is customized to the consumer (such as those offered in connection with the
`
`Registered Mark), the Applicant’s supplements are directed to overall health and wellness,
`
`including: collagen, antioxidants, sleep aids, cholesterol reducers, weight loss, and blood sugar
`
`reducers. These types of supplements are very distinct from the Registered Mark’s goods. For
`
`one, they are not formulated to address addiction management nor are the specific formulations
`
`matched to individual genetics. Rather, the Applied for Mark’s goods are meant to address general
`
`health concerns such as cholesterol, sleep problems, and weight loss (to name a few).
`
`In determining whether the parties' goods are so related that a likelihood of confusion will
`
`result from registration of the practicalities of the commercial world should be guiding.
`
`Consumers seeking to utilize the Applicant's Goods exercise great care when choosing a
`
`supplement. As such, consumers are likely to research their options and generally do not make an
`
`impulse purchase when it comes to supplements that they plant to consume.
`
`
`
`6
`
`

`

`Therefore, the level of care necessary here significantly minimizes any potential for a
`
`likelihood of confusion. See, e.g., In re NA.D., Inc., 754 F.2d 996, 999-1000, 224 U.S.P.Q.
`
`969,971 (Fed. Cir. 1985) (no likelihood of confusion between NARCO and NARKOMED because
`
`only sophisticated purchasers exercising great care would purchase the relevant goods). In finding
`
`no likelihood of confusion between NARCO for use with rental and leasing of hospital and surgical
`
`equipment and consultation services relating to the operation of such equipment and NARKOMED
`
`for use with anesthesia machines for use in surgery, the Federal Circuit held that “[a]n alert
`
`purchaser could readily distinguish them”. Id. at 999.
`
`D. Applicant’s Mark Includes a Coined Term and the Registered Mark Includes Familiar
`
`Terms
`
`Applicant’s Mark includes a coined term “GENRESTORE” without a readily understood
`
`meaning. Coined terms, i.e., terms that are not familiar to consumers, are typically held to a higher
`
`standard as something already known is distinguishable from the unfamiliar or coined. See In re
`
`General Electric Co., 134 U.S.P.Q. 190, 192 (C.C.P.A. 1962).
`
`On numerous occasions, the C.C.P.A. and T.T.A.B. have held that consumers can easily
`
`differentiate between terms that are known and terms that are unfamiliar. For example, in In re
`
`General Electric Co., the Court found consumers would easily differentiate between VULCAN
`
`and VULKENE for identical goods because they would recognize VULCAN as something already
`
`known, while VULKENE is a coined word. 134 U.S.P.Q. at 192. Similarly, in Faberge, Inc. v.
`
`Dr. Babor GmbH & Co., 219 U.S.P.Q. 848, 851 (T.T.A.B. 1983), the Board found no likelihood
`
`of confusion between BABOR and BABE, both for cosmetic products, and stated:
`
`we note that in a number of cases, the familiar versus unfamiliar
`comparison was made and while it may not have been the only factor
`which influenced those decisions, it was found to be highly significant
`in reaching the decision that confusion was unlikely to occur. The logic
`
`
`
`7
`
`

`

`behind the decisions is clear. One recognizes instantly that which is
`familiar. Conversely, that which is unfamiliar would be given closer
`scrutiny and in this way could be distinguished from the familiar.
`
`The fact that GENRESTORE is a coined or suggestive term finds in favor of not finding a
`
`likelihood of confusion.
`
`IV. Conclusion
`
`For all the foregoing reasons, Applicant respectfully requests that the Board find that
`
`GENRESTORE. when used in connection with the Applicant’s goods, is not likely to cause
`
`consumer confusion with the Registered Mark and pass the Application to publication.
`
`
`
`
`
`
`
`Dated: March 11, 2021
`
`Respectfully submitted,
`Attorney for Applicant
`
`By: /Reine Rooney/
`Reine Rooney
`Reine.glanz@gmail.com
`917-334-7043
`
`8
`
`

`

`EXHIBIT A
`EXHIBIT A
`
`j“G E N E u s —
`(
`
`CONSUMER
`6708.94
`743940
`
`
`
`REGISTER
`492(0;94 
`
`About v
`Science v
`GARS® v
`restoreGen® v
`Diagnostics MyGenx®
`*<!= 0,#, = 2*40> = '! 2> = 3#/!'#,' .?2@>
`U.S. Provide s
`Clinical Store
`8A0A !)#' 6&##,&0! 
`
`6:((6*:0;749 
`
`74;*:
`
`
`
`ontrolS
`ton
`and Non—S
`ton
`        
`roving Now
`  
`
`- Patented Neuro-Nutrient Fo mulations
` !" #$!%&#!'
`
`- Innovative Approach to Precision Addiction Management
`(!)#)*++ !,-! ,#'#!*#,#!./%
`
`- Specific Formulation Matched to Individual Genetics
`0+,#1#,$! %&#!.,-!(#)#&2#,'
`
`- Pro-Dopamine Regulator Decreases Addictive Behavior Cravings
` !"3!+%#4/&! 3, ''*#,#)5-)#! 6 )#/'
`
`

`

`EXHIBIT A
`EXHIBIT A
`
`
`
`j“G E N E u s —
`(
`     
`
` 

  
` 
`    
`  

   
`  
`  
`
`


` 
`  
`  
` 


`  
` 
`


`About v
`Science v
`GARS® v
`restoreGen® v
`Diagnostics MyGenx®
`1 B :  B 16: B     B >
`  = C
` 
`  
` 
`


` 
`U.S. Providers
`Clinical Store
`<:A

 9  
`: 
` !"#$"%& $'())*+$!,&$'())*-./0
`
`CONSUMER
`97;:<=86
`76>86:
`
`REGISTER
`68:@86 
`
`
`
`9?;91?:@768 
`
`A76@1?
`
`
`
`
`
`' rES‘tO reG e [’1
`I
`'
`d
`,
`
`
`
`
`
`An unprecedented 41 published clinical studies
`1  



23  

  
`


`have validated this neuro-nutrient technology for
`
` 
`

`

      
`re-balancing brain chemistry and optimizing
` 
`
` 
`    
`

  4 
`dopamine sensitivity and function to help with:
`


`     
`

     5
`
`.
`
`. Reducing addictive cravings
`6

 
`

  
` 
`. Optimizing brain health
`7  4 
` 
` 
`Increasing focus
`
`  
`. Enhancing energy levels
`8
`     
`. Relieving stress
`6    
`Improving overall well-being
` 
`  
`
`.
`
`Control Substance and Non-Substance
`9 : 
` 
`

;: 
` 
`Cravings Now
`9
` ;
`RestoreGen Relapse Controls Relapse
`.
`Rate [N] (9/9)
`
`Rate (N) (96)
`
`Reference
`
`Experimental
`.
`Length of time
`
`Patient Category
`
`6 * “.m-
`
`15m:
`
`was)
`
`lemma-
`
`—_——._
`_—-lE-_—
`
`Avera- nos
`References
`
`6   
`
`130(1433
`91.4 18.29
`
`117(41-7)
`158
`
`

`

`EXHIBIT A
`
`  
`


` 
`
`
` 
` 
`
` 
`  

 !"
`#$% & '  $(()*+,)
`
`( -  .
`$'+

`$ $/ ((0.12 3 4 
`5
`
`6

`-

 6
`' 78
` 9   
`
` 
`
`>?G"> 
`&: G%>
`
`: ;:  
`
` 

 < 
` = 2=#%< 2


`>8 2 %? 
`

 @$ 
` &
`%&
`:>G
`
` (0A*/,5  (B  0 (*C*);(*),+*ABA;D0(B
`
`* ?
`E  7
` 
`'$


`#
` 
` #   
` 
`

 &
`"  

 <  2 %F
` 
`&2 &72G":> 
`':"72
`G  
` < 


`> > 7 4 4F %

G - %
`$  #
`& !'

" 7
`
`" (DD0(+DD
`
`D > 
`
` 
`
`
` ((04+ $
`7

`+7 " / 77"51

 :


` 
` 7  
`"


`'$

7
`
`' G %
`% 7


`2&&
`G
` GFG
`G 


`7# %%
`F#%
`F/ -5  % /'5 
`
`
`
`7#ƒ G 
` ƒ ?7G„ ƒ ?
`„ ƒ  $
`  % ?
`9„
`
`'
`/'5"

-&
`
`7  <  


`$2< %$7% $
`> 


`



%  
`
`? 
`
`
`G #
`%%
`:+


`#

  
`
`


`'  $/

# (0(5
`
` G '  &
` G
`
`B G
`

`/G?,,*C5"%7
`7

`+7 >
`F
`
` #  
`  

 7 7G#   
` G
`

/G5
`
`

 &
`"  - 
` < %F
` 

G - %
`.'
`% %
`$  = <  2 7 4 4 F % !


`>  "
`
`7 
`
`G 
`(/*5*(+*,
`
`A  
` 
`
` $
`# #
`$
`
`
`   

 "
`#$%&&F< &" D,()+(**
`
`) &
`  
`=> 
`'
`"%
`


`
`
`$ $
`
`
`+#
`(+  

 &? &
`"-? +G
`G
`
`
`-%< 


`> 2 !"
`#$%& &
`"  B,/05CC)
`
`,  7+$7  
`"


`:

G /7":G5=
` 
`G    ; $   G
`G

 


`>? 
`"


`
`
`:+


`%$ 
`% $
`%78 2 %

 @< 2?%G  G
` (0B/5*A+DB
`
`HIJKLMNOLPQJR
`
`S T
`
`UPKSVWISXINYQI
`ZP[LO\]
`
`^_`a`bcde`feghcd`ciijkl`
`m"F
`$ ((0@





  
`
`n
`9

   
`
`
`$$ 
` 7#  
`$
`o
`
`pq`a`rebcde`ijcstufei`vjlw`ctgjelx`cti`yz{|`vjlw`tjswlbc}ef`
`m7F
`$ ((0@


`

 
`$

$
`
`
`  

#
`
`D 
`$ ((0@  
`#

A


`
` ((0@+
`
`
`

.
`$o
`
`~^`a`rebcde`ijcstufei`vjlw`|€|`cti`fhflctke`chfe`vjlw`tjswlbc}ef`
`m7#*FF
`$ ((0@ 
`$ 


` 




` 
`$
`$ <

‚o
`
`

`

`EXHIBIT A
`
`  
`



` 


`
` !"#$$%&'()*+,!(-,(!!,)*.+,.
`kj?'V>jk 
`gWhViNjk
`
`WkXjkV
`,/0
`
`12 3345 6 47
`8
` 6


`9


`':;!-' "#$$%&.<..**((('.(+,,',
` *.*!/(+(/=>?,@,,'(A!,/</,/0
`m<o V++ o ?mkVp o ..?p o X!+ N/?)p
`
`gl'h'gmlV>Wkj 
`
`nWk>ml
`
`i=V=n.A,. g(+(V.
`B 3C45 6 4D7


`

E 4 

6

 8
` 1FGF
`#,(!!. !"#$$%&',.!!..!!*.,+
`<.(<.-A<+((/.(,/-. !./+.,@--H0
`
`2I JK458
`  7
`

7 LM 9 

6

 EE

6 9
`>N.+$%OP-'<! "#$$%&Q"#$$%&RS,-. ,.(/T+ (/.='+'
`(( -(,=U-A.S.(+((/S-- .(=>..(<-',,
`(,*=',,,<.*..*<(/!</**!,.,!
`,.+.(=V+ !"#$$%&N.+/*.(.(*-/(/A,.+((/+!,=
`V*++((/S'(A!'A(-/< ,,+*S'+,-'(.
`*.((/ ,-.,/(/='(/T.*.(/QR(-/<.!!(.,
`+,S<.+((/N.+'(!'-,S.',/(*!*
`.--/?WX='(((/*,*='+.,.,/-**,='./.(*
`-/.S'+.*S,A+,*(/-.,.-/<
`
`,!.(.((/,,!./(!=N/+*! ((,((-
`(!(,/<+ ,..=U**(/'.*.'.-.,.,+, ,
`,(A!!..<+' !<.(!-='*.@"#$$%;*.,.-
`+,.='(.!-( .Y(A.='!.('("#$$%&,/,+..
`.*<(.<(+!/(0
`
`IF Z[45

ED 

8
` 

64

D7  7
`X.!..,/S'(T<.+AS.<(!-.\%,
`-.!.]^,,*,='(//!*.A,(!(/,,,/
`((,(*!.(/*.A,=')*.+,+(!+(.,=N*.A'
`(!.('-!!A.,!..,,/_-. S-+-+*(,-(!+.
`.!/S+.,A-. S+.,+,(@ !S-+(..*.* ,=
`N;!(/S'((<,+(!0
`
`GF `[45D8
` 
` Fab 



6 
`4D76

 7 
`'A< "#$$%&.<.- -,'(+(..A./,/-. ,
`+<(/'A.AS!(/+,,;!(//A.((+.A!.-/,-(
`0
`
`cd C[45

94   7e
`

`'A< !V<)(*.+A./.<f<..'(A./,,
`-, ((/(=',,.(*,.!,(+(<'.<.+((!/,+.- /
`,@(,*,+.+@-+',,='-!A"#$$%&,.,/ !
`"#$$%&((/*( ((/(-.!='(+(,-,.( "#$$%&@.+(H0
`
`

`

`EXHIBIT A
`
`  
`




` 



 




`  


`vuK7ECuv 
`@fWEt>uv
`
`fvAuvE
` !"#$%&'&&(()#&*+,,-. /0"&)$1()#(23#$%&'&&(/&$4'&""&5'46)37(140$"&87
`#$%&()60&5619/%&5 0!"81/&:/&"%&:8/&5!0&5:619!"6%6)4:$(5$#6;#&/:'$"&6(&:&%& $ &0)<56 &/&()
`@?7W7@?ECfvu 
`LfvC?
`6(=6(5)2#$)$()6<5&9/&""$()"#$55(& /1&"&%&/$4&$/"$;3>426 &?@#$"$" !(5$;/&$)&/"&("&
`:);&)#&/(&"":$(57#$%&()60&5"!')&"6;(" 1/&:$""&/)6%&(&"":2#60#72&01&<&"9&06$426)#!/
`5$!;#)&/8>@37()!/(8>@8!/4!(;&")26)#165AA#$""#2(&B!6%$&() !(0)6($619/%&1&()")2#$)
`'!)w E06&(0& w KvEx w /&")/&K&(x w A6$;(")60" >4K&(Mx
`"#&#$"#$5(@(0&/)$3C#&;/&$)&")0#$(;&8)#!;#8#$"'&&(6(!/$59)&55$!;#)&/8D@3E#&((;&/#$"
`t3E3L/%65&/" @6(60$E)/&
` 50/$%6(;"F2#60#6"(&$/16/$0!!"G$""#&6"B!6)&'&"&$)H3H &&)I,H-9!(5"<$(5"#&0$((256/&0)
`#&/$99&)6)&/$)#&/)#$('&)#&%60)61 6)3J&/)#!;#)"$/&$"1!0#&"":)/!'&5:$(5'!"4$(5"#&#$"
`'&01&&"":5&9&(5&():$(51/&!)2$/5< 0!"&53J&/9"40#;6")$(5KL$/&$"619/&""&526)#*+,,-.
`$(5#$%&$;/&&5)#5 ()#&$()6<5&9/&""$()")#&4#$5'&&(0("65&/6(;37"&("&)#$)#&/&M$19&1$4
`"&/%&$"$(&(0!/$;&1&()))#&/")5)#&"$1&3(42$487N!"))#!;#));6%&4!!/0&0)6%& 6/")<#$(5
`$00!()"O
`
`PP QR 
`S

 T 
`  U 
`V#6&6)6"#$/5)'&6&%&2#&(&%&/7#$%&$")/&"" !%&/$57 !(5)#$)2#&(7)$=&*+,,-.)#&")/&""6"
`;(&$ )&/$'!)(&#!/3W27=&&9*+,,-.6(1490=&)$)2/=O
`
`PX YY 
`S



`T   
`Z1$[6(;\]()#& 6 )#5$4 )$=6(;*+,,-.72=&!96('&5$(5"#!)&5!)^_7)]";(&\]14#!"'$(5$"=&5
`_2#$)6";(&`]_>40/$%6(;"8140/$%6(;"\Z
`
` Qa 
`S
` b
`





cc 


`C$=6(;*+,,-. /$(!1'&/ 1()#")#6(=6(;)#$)72$" 6(&$(5)#&(5&065&5)")9)$=6(;6)3E(7
`56"0%&/&5)#$)14$(M6&)6&"#$5/&)!/(&5^$(57 6;!/&5!))#$))#&96#&9&5/&5!0&514")/&"""(27")$4
`(*+,,-.O
`
`d Qe 
`S  
` b
`


`f>K\72$()))#$(=A/3+!1 /)#6"$1$[6(;9/5!0)^7)#$""$%&5146 &\O
`
`gh  
`

i  

U


`b
`

 
`
`j/*+,,-.<7$1 &&6(;'&))&/%&/$F(=(&&9$6($)$\G$ )&/(4(&5$43k&"87#$%& &)0$1$5$43
`]V2]6"$70$("$4\O
`
`lP Q 
`S  
` 


` b
` 

Um

 i Xndo
`Z )&/72$")$=&( V&'!)/6(p?87'&;$()$=6(;*+,,-.37($'!)(&1()#7#$5$9/ !(5/&"9("&)
`*+,,-.2#6&71$6()$6(&5(E!'M(&37 &)"6;(6 60$()4'&))&/8"9&06 60$4q7#$%&$(6(0/&$"&6(&(&/;48$
`5&0/&$"&6(0/$%6(;"$(5%&/$'&))&/1537 6(514"& 0!))6(; /6"=4 /6&(5"8$(5&%&(0#$(;&5145&$5<
`&(5N'3"87&(/&56(0&;&37)"&&1")#$)146("6;#)8N!5;&1&()$(51)6%$)6(/&$4619/%&53C#&/&6"
`619/%&1&()6(1415$(5&%&(1652&6;#)""3C#&1")$1$[6(;)#6(;6")#$)7#$%&[&/0/$%6(;"$(5$
`"&("& (/1$04() &)()#&E!'M(&$(&3Z
`
`go rs 
`S  i  U
` 

mi  



 b 


`f%&/<)61&7#$%&)/6&5)26)#5/$2 /114$()6<5&9/&""$()1&560$)6(@41'$)$80$!"6(;"&%&/&($!"&$8
`%&/)6;86()&("&$(M6&)48"!(9&$"$())#$)70!5&(5!/&)#&"&"419)1" /(4$5$4'& /&5&0656(;)
`
`

`

`EXHIBIT A
`
`   
` 



      
`   
`

   
`
`


`   

  

 

 !     
` 
` 
`dln\ld 
`ij\kMld
`
`idZld\
`  
` 


` 



 
` 
`


`       

 "
`  # 
`          
`
`     $
`mj[m\idl 
`
`cid[m
`
`%&'()*+,-'.+/0012(1'3+451312163*+'3+7899:;+
`[ o \  o n[d\p o  n p o Z  Mn hp
`
`k\c  
`
`\
`<63=6+>)5.63?+<@A+B6.15=+<)01213)+451312?+C65).?+D-)E'3
`F   G     
`  
`      $
`
`H=5)+B-1)0?+</4A+CI'-)*+J-)6(.)3(+630+K)2'L)-=+4)3()-?+B5'-106+
`FM
`  
` 
`    



    
`
`  
`
`"  M 
`    
`
` 

 
` 
`  
` #
`       N
`
`<6-O+C+P'50?+<@+QR-',)**'-+).)-1(&*?+S31L)-*1(=+',+B5'-106+@)R6-(.)3(+',+T*=2I16(-=+4'55)E)+',+<)01213)
`QP613)*L155)+
`F     #
`    

#



        
`    


`     

    


` $
`
`U'I3+P1'-063'?+@>H+630+</4+Q+U'I3+P1'-063'+H1,)+V3I632).)3(+K)2'L)-=+4)3()-?+B(W+H6&0)-065)?+BH
`N

   
` X
`   

  
`  
`#        
`
`    
` 


`"

`   N
`
`7Y+Q+63+60012(1'3+-)2'L)-=+*R)21651*(
`FX               

    
`   

 
`  
`   
`
`  Z
` X
` 

` 



 
`[    #
`     #

       #


` 

 
` 
`
`    
`  

     \     
`   

 X


`

     


`  \ 
`#
` 

`

# 

 
` 
`]  
`
`  G ^

    
`
`"  
`    

   
` X  
`  _#
`  

     X N
`
`P-)E+>',,.63+Q'`3)-?+P'AC'a)-+451312Q+@)3L)-?+4'5'-60'
`Nb      
`


`  

   
`  


` Xc"Z 
`d
` eG

f 

    



 


`  
`

"
`
`
`
`  
`  
`!   
` 
`


`   
`


`     g
`
`
`   N
`
`JI'.6*+<2H6&EI513?+<@?+TI@A4)3()-+,'-+T*=2I16(-=?+H6`-)32)?+</
`N

   
`
`  
`    
`   h   



`
`  
`   
`   g 
`
` "
`  \ 



   
`  

   

  


`      
`

     

`
`
` 
`#   

  
`    

   N
`
`

`

`EXHIBIT A
`
`     
` 

 
` 

   
`
`              
`
`     
`    
`
`              
`
`>?@#PKL
`LKL@
`
`
`
`LKN@KL
`
`>JN?N>J @LK
`
`BLJ
`
`

R @  R L@ R   R   P S
`>?>
`
`#@ B
` >   @
`
`BLMNKL BLJ
`
`K N? #>O
`
`?C
`
`K C
`
` @
`
`   A
`
`    
`      
`
`B  C DEEFDGGFHIIE
`
`      
`

 
`
`
`
`